Patents by Inventor Imke Mulder

Imke Mulder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230310517
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Application
    Filed: January 5, 2023
    Publication date: October 5, 2023
    Inventors: George GRANT, Angela Margaret PATTERSON, Imke MULDER, Seanin MCCLUSKEY, Emma RAFTIS
  • Patent number: 11723933
    Abstract: The present invention provides a strain of Bacteroides thetaiotaomicron and derivatives thereof, and the use of said strain or derivatives in treating inflammatory, autoimmune and allergic disorders. The invention also provides pharmaceutical compositions, nutritional supplements, feedstuffs, food products, dietary supplements, and food additives comprising said strain or derivatives.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: August 15, 2023
    Assignee: CJ BIOSCIENCE, INC.
    Inventors: Angela Margaret Patterson, George Grant, Imke Mulder
  • Patent number: 11504405
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing lung injury or lung disease.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: November 22, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Mulder, Alexander Stevenson, Helene Savignac
  • Patent number: 11433106
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: September 6, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Patent number: 11414463
    Abstract: The present invention relates to Roseburia flagellin, and/or a polynucleotide sequence encoding said Roseburia flagellin, and/or a vector comprising said polynucleotide sequence, and/or a host cell, including bacteria, comprising said vector, and/or a host cell, including bacteria, comprising said polynucleotide sequence, for use in modulating the inflammation of a tissue or an organ in a subject.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: August 16, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Angela Patterson, Edouard Monnais, Imke Mulder
  • Patent number: 11389493
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: July 19, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Publication number: 20220218766
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 14, 2022
    Inventors: George GRANT, Angela Margaret PATTERSON, Imke MULDER, Seanin MCCLUSKEY, Emma RAFTIS
  • Patent number: 11331352
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: May 17, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Patent number: 11266698
    Abstract: A first aspect of the invention relates to the bacterial species Roseburia hominis for use in: regulating the immune system of a subject treating an immune disorder; treating an intestinal disorder; improving intestinal microbiota; regulating the innate immune system of a subject; regulating the adaptive immune system of a subject; regulating appetite in a subject; promoting Tregs and immune tolerance; promoting gut health in a subject; and/or maintaining immune homeostasis in a subject. Further aspects of the invention relate to compositions comprising Roseburia hominis.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: March 8, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Imke Mulder
  • Publication number: 20210275606
    Abstract: This invention is in the field of compositions comprising bacterial strains isolated from the mammalian digestive tract and the use of such compositions in the treatment of disease.
    Type: Application
    Filed: December 14, 2020
    Publication date: September 9, 2021
    Inventors: Sam YUILLE, Helene SAVIGNAC, Suaad AHMED, Sarah REID, Imke MULDER, Nicole REICHARDT, Emma RAFTIS, Anna ETTORRE, Grainne LENNON
  • Publication number: 20210275607
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing lung injury or lung disease.
    Type: Application
    Filed: January 15, 2021
    Publication date: September 9, 2021
    Inventors: Imke MULDER, Alexander STEVENSON, Helene SAVIGNAC
  • Publication number: 20210196765
    Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or stability of the microbiota of a subject.
    Type: Application
    Filed: September 30, 2020
    Publication date: July 1, 2021
    Inventors: Ian JEFFERY, Fergus SHANAHAN, Paul O'TOOLE, Alex STEVENSON, Imke MULDER, Helene SAVIGNAC
  • Patent number: 11040075
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: June 22, 2021
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Publication number: 20210145900
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Application
    Filed: August 28, 2020
    Publication date: May 20, 2021
    Inventors: George GRANT, Angela Margaret PATTERSON, Imke MULDER, Seanin MCCLUSKEY, Emma RAFTIS
  • Publication number: 20210054031
    Abstract: The present invention relates to Roseburia flagellin, and/or a polynucleotide sequence encoding said Roseburia flagellin, and/or a vector comprising said polynucleotide sequence, and/or a host cell, including bacteria, comprising said vector, and/or a host cell, including bacteria, comprising said polynucleotide sequence, for use in modulating the inflammation of a tissue or an organ in a subject.
    Type: Application
    Filed: June 9, 2020
    Publication date: February 25, 2021
    Inventors: Denise KELLY, Angela PATTERSON, Edouard MONNAIS, Imke MULDER
  • Patent number: 10898526
    Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or stability of the microbiota of a subject.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: January 26, 2021
    Assignee: 4D Pharma PLC
    Inventors: Ian Jeffery, Fergus Shanahan, Paul O'Toole, Alex Stevenson, Imke Mulder, Helene Savignac
  • Patent number: 10864236
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: December 15, 2020
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis
  • Publication number: 20200384038
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Application
    Filed: April 10, 2020
    Publication date: December 10, 2020
    Inventors: George GRANT, Angela Margaret PATTERSON, Imke MULDER, Seanin MCCLUSKEY, Emma RAFTIS
  • Patent number: 10851137
    Abstract: The present invention relates to Roseburia flagellin, and/or a polynucleotide sequence encoding said Roseburia flagellin, and/or a vector comprising said polynucleotide sequence, and/or a host cell, including bacteria, comprising said vector, and/or a host cell, including bacteria, comprising said polynucleotide sequence, for use in modulating the inflammation of a tissue or an organ in a subject.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: December 1, 2020
    Assignee: 4D Pharma Research Limited
    Inventors: Denise Kelly, Angela Patterson, Edouard Monnais, Imke Mulder
  • Patent number: 10780134
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: September 22, 2020
    Assignee: 4D Pharma Research Limited
    Inventors: George Grant, Angela Margaret Patterson, Imke Mulder, Seanin McCluskey, Emma Raftis